Back

P2Y12 inhibitor intensity de-escalation in patients with acute coronary syndromes

European Heart Journal

8 March 2023
Organised by: Logo
Read full article
ESC Journals CARDIOVASCULAR PHARMACOLOGY CORONARY ARTERY DISEASE, ACUTE CORONARY SYNDROMES, ACUTE CARDIAC CARE Acute Coronary Syndromes Interventional Cardiology

Contributors

Gjin Ndrepepa
Gjin Ndrepepa

Author

Adnan Kastrati
Adnan Kastrati

Author

German Heart Center Muenchen Technical University of Munich Munich , Germany

You may be interested in
thumbnail
Congress Presentation
Comparative efficacy and safety of de-escalation, abbreviation, and standard potent P2Y12 inhibitor based DAPT strategies after acute coronary syndrome: a network meta analysis
21 March 2026
thumbnail
Congress Presentation
Pre-treatment with P2Y12 inhibitors in acute myocardial infarction with cardiogenic shock
30 August 2025
thumbnail
Congress Session
Implementation in real-world practice of ESC Guidelines for the acute management of patients with NSTE-ACS
27 August 2023
thumbnail
Congress Presentation
Choice of P2Y12 inhibitor and clinical outcomes in the AUGUSTUS study: support for an individualised approach
30 August 2020

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources